SAN DIEGO, Oct. 9, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chairman and CEO Jim Joyce will present at the RedChip 15 th Annual Fall Small-Cap Conference this Thursday, October 11, 2012 at the Palace Hotel in San Francisco. A live webcast of the presentation will begin at 2:15 p.m. Pacific time ( 5:15 p.m. Eastern time) and can be accessed online at: http://redchip.com/visibility/conferencePages/SanFran2012/conferenceMain.asp?page=preregister The webcast and archived replay of the company's presentation will be available approximately one week following the presentation at www.redchip.com/conference. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) About Aethlon Medical, Inc. The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with DARPA that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com. Contacts: James A. Joyce Chairman and CEO 858.459.7800 x301 email@example.com Jim Frakes Chief Financial Officer 858.459.7800 x300 firstname.lastname@example.org Marc Robins 877.276.2467 email@example.com SOURCE Aethlon Medical, Inc.